Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with suitable veins for cannulation or repeated venepuncture~* Pre-dose assessment judged without remarks by the investigator~* Have a body mass index (BMI) between 18 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg~Exclusion Criteria:~* Abnormal vital signs, after 15 minutes supine rest, defined as any of the following:~* Systolic blood pressure \>140 mm Hg~* Diastolic blood pressure \>90 mm Hg~* Heart rate ≤45 or \>85 beats per minute~* Lack of normal phenotype for BuChE (Butyrylcholinesterase)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Intravenous solution given as a single ascending bolus dose
- 2 (Type: EXPERIMENTAL): Intravenous solution given as a single ascending bolus dose followed by a single infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).